Axsome Therapeutics, Inc.
AXSM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001579428
In the last 90 days, Axsome Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 505 institutions reported holding it in 13F filings for Q2 2026, worth $9.34B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Axsome Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 171
- −2 vs. Q2 2021
- Shares held
- 19.1M
- −2.72M (−12.5%) vs. Q2 2021
- Total value
- $627.3M
- −$841.5M (−57.3%) vs. Q2 2021
- New holders
- 35
- 67 more added
- Sold out
- 37
- 39 more reduced
3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXSM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 505 | $9.34B |
| Q1 2026 | 410 | $6.41B |
| Q4 2025 | 399 | $6.86B |
| Q3 2025 | 355 | $4.51B |
| Q2 2025 | 348 | $3.95B |
| Q1 2025 | 353 | $4.37B |
| Q4 2024 | 292 | $3.15B |
| Q3 2024 | 280 | $3.48B |
| Q2 2024 | 257 | $3.28B |
| Q1 2024 | 259 | $3.09B |
| Q4 2023 | 245 | $3.07B |
| Q3 2023 | 227 | $2.65B |
| Q2 2023 | 231 | $2.61B |
| Q1 2023 | 197 | $1.97B |
| Q4 2022 | 219 | $2.32B |
| Q3 2022 | 188 | $1.15B |
| Q2 2022 | 174 | $826.7M |
| Q1 2022 | 175 | $787.4M |
| Q4 2021 | 167 | $704.2M |
| Q3 2021 | 171 | $627.3M |
| Q2 2021 | 176 | $1.51B |
| Q1 2021 | 184 | $1.31B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Axsome Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −3,634−100.0% | Sold out |
| Mutual Advisors, LLC | 0 | $0 | 0.00% | −2,995−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −2,800−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −786−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −725−100.0% | Sold out |
| Central Trust Co | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Pictet Asset Management Ltd | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |
| First Horizon Corp | – | – | – | – | Not filed |